2m 2m 2m 2m 2m 2m 2m
Immage Biotherap (IMMG)
OTC
$0.000001$0.00 (0.00%)
Price as of Feb 12, 2026- $151.00Market Cap
- 0.00%1-Year Change
- BiotechnologyIndustry
Immage Biotherap (IMMG)
$0.000001$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.000001
$0.000001
$0.000001
1-Year Range
$0.000001
$0.000001
$0.000001
Latest Close$0.000001
Change
$0.00 (0.00%)
Volume500
Market Cap$151.00
Shares Outstanding151.7M
P/E (TTM)-0.00008
Diluted EPS (TTM)-$0.01
Enterprise Value$2,731.00
Information as of 02/12/2026
Company Profile
IMMAGE BIOTHERAPEUTICS CORP.
https://www.immagebio.com$151.00
Market Cap
-$1.8M
Net Income
Sector: Healthcare
Industry: Biotechnology
10411 Motor City Drive, Bethesda, MD, United States, 20817
866 692 2939Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.
Key Executives
- Mahesh Narayanan
- Elton F. Norman
- Zhi Cong Mou
Current Ownership Distribution
- Other151.7M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)